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Pressure ulcers (PUs) are localized injuries of the skin or underlying tissue caused by
prolonged pressure, exposure to shear forces or friction. PUs represent a major concern for
hospitalized patients and the health professionals responsible for their wellbeing. inten-
sive care init (ICU) patients are at high risk of PU development, and the development of PUs
can significantly extend the length of time a patient must remain in the ICU. Patients with
PUs experience significantly increased morbidity, mortality and financial burden. A sig-
nificant amount of evidence has accumulated indicating that PU prevention is an essential
component of patient care. However, standardized guidelines and protocols for PU pre-
vention in ICUs have not been universally implemented. This review aims to describe and
analyze an optimized PU prevention care bundle based on the best available evidence and
existing national guidelines. We distilled the available information into five main topics
important for PU prevention: Risk Assessment, Skin Assessment, Support Surfaces,
Nutrition and Repositioning. Further larger scale studies are needed to clinically verify the
effectiveness of the care bundle.
Copyright © 2015, Chinese Nursing Association. Production and hosting by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pressure ulcers (PUs), also knownas a pressure sores, decubitus
ulcers and bed sores, are localized injuries of the skin or un-
derlying tissue that most often occur over bony prominences
andwhich canbecausedbyany combination of pressure, shear
forces or friction [1]. PUs are internationally recognized as an
important andmostly avoidable indicator of health care quality
[2]. PU severity is described using a Stage I through IV(X.-L. Zuo), mfj1127@126.
Nursing Association.
Association. Production
://creativecommons.org/classification system, with Stage I representing the earliest
stages of PU formation, and Stage IV representing the severest
grade of PUs that are characterized by full thickness tissue loss
and exposed bone, tendon or muscle tissue [1]. PUs occur most
frequently over bony prominences, and the most common PU
vulnerable locations include the sacrum, coccyx, heels and ear.
Compression of the soft tissues over the bony prominence
causes tissue ischemia of the skin, muscle and fascia in the
compressed region between the skin surface and bone. Tissue
ischemia at the point of compression is largely the result of thecom (F.-J. Meng).
and hosting by Elsevier (Singapore) Pte Ltd. This is an open access
licenses/by-nc-nd/4.0/).
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in turn, blocks the local supply of oxygen and nutrients at the
capillary interface as well as the venous return of metabolic
wastes. If pressure is prolonged, metabolic wastes accumulate
and inducea local vasodilatation response.The inductionof the
vasodilation response contributes to local edema, further
compressing the small vessels in the affected region and
increasing edema and ischemia in a positive feedback loop [2].
Ultimately, this cycle results in the local tissue death that cul-
minates in the formation of a PU.
Patients admitted to intensive care units (ICUs) are at a
higher risk of developing PUs than patients admitted to gen-
eral care. A review of ICU related literature from 2000 to 2005
indicated a PU prevalence in the ICU of 4e49% and an inci-
dence of 3.8e40.4% [3]. The 2009 International Pressure Ulcer
Prevalence Survey indicated that facility-acquired PU preva-
lence rates were highest (12.1%) in the medical ICU (MICU) [4].
Studies have reported an association between PUs and
increased morbidity and mortality [5]. PUs can also lead to
serious infectious complications, like bacteremia and sepsis
[6,7]. Because of these factors, PUs have been reported to
extend the duration of a hospital stay by amedian of 4.31 days
[5]. Due to the adverse effects associated with PUs, PU pre-
vention in the ICU is critically important.
PU prevention and treatment can consume limited re-
sources in large quantities, including nursing care andmoney.
In the United States, the economic cost of PUs ranges from 9.1
billion to 11.6 billion dollars per year [8]. In the UK, the total
cost of PU care in the period from the years 1999e2000 ranged
from 1.4 to 2.1 billion pounds per year, a cost representing 4%
of the entire National Health Service expenditure [9]. In
Australia, the cost of treating a single Stage IV ulcer has been
estimated at more than $61,000 Australian dollars [10]. A
recent systematic review argued that the cost of PU treatment
per patient per day is much higher than prevention [11].
Therefore, PU prevention is a critically important element of
patient care, and additional attention paid to PU prevention is
likely to meaningfully improve patient care and reduce the
economic costs associated with treatment in the ICU.2. The PU prevention care bundle
2.1. What is a care bundle?
A “care bundle” is also sometimes referred as a bundle of care,
a patient care bundle, a prevention bundle, or a nursing
cluster bundle. These terms interchangeably refer to the
practice of creating a series of evidence-based treatment and
nursing measures to deal with incidental risks or refractory
clinical [12]. Thus, a care bundle is a collection of quality of
care management ideas that can be implemented in the ICU
with the goal of promoting cooperation among different
healthcare disciplines and promoting the translation of clin-
ical guidelines to clinical practice.
A care bundle usually includes three to six elements, each
of which is supported by evidence from randomized
controlled trials (RCTs) or systematic reviews (SRs). All the
interventions in the care bundle must be performed in pa-
tients continuously, and the bundle is being incorrectlyapplied if the health care practitioner is selecting only one or
two measures from the bundle to perform. Care bundles are
thought of as systems that are greater than the sum of their
parts; only when the interventions are performed simulta-
neously can the care bundle achieve its maximum effect.
Implementation of individual elements of the care bundle
violates the spirit of the cluster intervention strategy and will
not produce the desired results. Different cluster bundles have
been specifically designed for the management of different
diseases, and some common cluster bundle elements can be
incorporated or eliminated to meet the specific challenges
posed by individual diseases. In other words, there is no single
compulsory therapeutic regime.
The existing PU care bundle was based on the best avail-
able evidence and guidelines: the International guidelines
[1,13,14] and the guidelines of the Registered Nurses Associ-
ation of Ontario (RNAO) [15]. These universal guidelines
describe PUs, and include evidence-based recommendations
incorporated from the results of RCTs and SRs. The current
review further develops and specializes the recommendations
of the PU prevention care bundle for adult patients hospital-
ized in ICUs. This review identifies five key elements of PU
prevention and care: Risk Assessment, Skin Assessment,
Support Surfaces, Nutrition and Repositioning.
2.2. Quality of evidence and definitions
Evidence quality was assessed according to the Grading of
Recommendations Assessment, Development and Evaluation
(GRADE) Working Group criteria. The GRADE criteria are
increasingly being adopted by organizations worldwide, and
this system for rating the quality of evidence and the strength
of recommendations is explicit, comprehensive, transparent
and pragmatic. The GRADE system classifies the quality of
evidence in one of four levels [16]: 1) Very high quality, further
research is very unlikely to change the consensus of confi-
dence in the estimated effect; 2) High quality, further research
is likely to have an important impact on the consensus of
confidence in the estimated effect and may change the esti-
mate; 3) Low quality, further research is very likely to have an
important impact on the consensus of confidence in the
estimated effect and is likely to change the estimate; 4) Very
low quality, any estimated effect is very uncertain.
Evidence based on RCTs and SRs is frequently regarded as
veryhighquality evidence; however, confidence in theevidence
may decrease for several reasons. These reasons include: 1)
Study limitations, 2) Inconsistent results, 3) Indirectness of ev-
idence, 4) A lack of precision and 5) Reporting bias. Conversely,
confidence intheevidencemaybeincreasedforseveralreasons,
including: 1) A large effect, 2) Plausible confounding factors that
couldhaveopposed theeffect and3)Dose response grading [17].3. Implementation process
3.1. Preparation before intervention
3.1.1. The formation of a PUs quality control team
For effective implementation of the preventative care bundle,
a team should be assembled and practical measures or guides
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include the department's head nurse (who should also be the
team leader), the head of the department, a PU therapist, a
doctor, a clinical nurse specialist, and the department of
infection control and management. The team leader should
structure and organize comprehensive programs for the care
bundle to educate all the ICU nurses and physicians.
Furthermore, once education has been completed, testing
should be performed to ensure every member of staff reached
a standard level. Additionally, the teams clinical nurse
specialist should have good communication and teaching
skills, a high level of independence, and the ability and qual-
ifications to eventually progress to the level of senior nurse.
3.1.2. The development of quality management objectives
and rules
The assembled team should hold regular meetings to discuss
and formulate objectives regarding infection and risk man-
agement and skin care according to the relevant policies of the
ICU. Additionally, the team should draft management stan-
dards and reporting requirements. Hospital protocols for the
prevention of PU development should be instituted. These
policies should include standards for Risk Assessment, Skin
Assessment, Support Surfaces, Nutrition and Repositioning.
3.1.3. Assigning responsibility
Prior to any intervention, the head nurse should monitor the
implementation of the care bundle to make certain that the
care bundle is put into effect in accordance with the estab-
lished standards and to make any necessary corrections to
procedure. The goal is to prevent problems and discover hid-
den dangers before any issues with care bundle imple-
mentation affect patients.
Clinical nurse specialists are responsible for recording pa-
tient's fundamental information and biochemical results.
Additionally, the clinical nurse is responsible for collecting
daily ICU records, including the patient numbers of newly
admitted ICU patients, the total number of patients and the PU
and skin status of all ICU patients.
Critical care nurses must identify the appropriate in-
terventions to prevent PU development. They must also
continuously educate themselves to ensure that they are
knowledgeable concerning the manufacturer's recommenda-
tions for all devices used in the care of the patient. When
suspecting that a patient has or is at risk of PUs, the nurse
should promptly report this information to the responsible
physicians, examine the patient and take appropriate
measurements.
3.2. Applying the care bundle
The team leader must track the implementation of the care
bundle each day to make certain that each of these measures
are continuously monitored: Risk Assessment, Skin Assess-
ment, Support Surfaces, Nutrition and Repositioning. The
consistent implementation of these five elements can help
nurses easily master the essentials of the care package.
Additionally, use of the care package can ensure that nursing
interventions for high-risk patients actively avoid potential
adverse events and complications. Each patient has uniquecharacteristics and health conditions, and many intrinsic and
extrinsic factors have been associated with PU development.
Therefore, when considering all PU risks, ICU nurses must
account for each patient's individuality and special needs.
3.2.1. Risk assessment
3.2.1.1. Risk factors. Prompt and accurate identification of risk
factors associated with PU development is the first step in
effective prevention. There is no single factor that can account
for PU risk in the ICU; rather there is a complex interplay of
factors that can increase the probability of PU development.
PUs develop because of extrinsic and intrinsic factors. The
main extrinsic factors are decreased tissue perfusion due to
pressure on the skin, shear stress or friction and maceration
of the skin, which may remove epidermal layers and render
the skin more vulnerable to further injury. Intrinsic factors
patient specific factors that may exacerbate effects of
extrinsic factors [18]. When evaluating intrinsic risk factors
within the conceptual framework of PU etiology, three major
intrinsic risk factors should always be considered: mobility
(including mechanical ventilation and consciousness), tissue
perfusion and patient age [19,20]. Even though they have only
been examined by a small number of PU studies, the following
factors may also be important: nutrition, severity of patient
morbidity (including infection), hematological measures, skin
moisture, body temperature and immunity. There is minimal
evidence that race or gender are important risk factors for PU.
Each of the major intrinsic risk factors is discussed in detail
below.
Immobility is a significant PU risk factor. This is logical:
people who are unable to reposition themselves are more
likely to be exposed to prolonged external mechanical forces
[21]. The risk is especially high for patients subjected to pro-
longedmechanical ventilation or the use of sedatives, and this
is because these patients are likely to experience a lowered
level of consciousness and decreased sensation [20].
Tissue perfusion related variables include edema, diabetes,
vascular disease, circulation and blood pressure. The impor-
tance of these variables suggests that factors that impair cir-
culation will increase the probability of PU development. Some
medications that target these variables may act as protective
and therapeutic factors; however, some of these medications
may also reduce initiative mobility and intensify regional
ischemia and hypoxia [22e24]. There is strong evidence that
the use of vasoactive drugs, vasopressors and dopamine in-
creases the probability of PU development [25]. One RCT re-
ported that a mean blood pressure lower than 60e70 mmHg
was associated with impaired skin condition [26].
Age is a significant variable in the ICU, and advanced age
contributes to the risk of PU development. Elderly individuals
have less subcutaneous fat, decreased dermal thickness and
decreased sensory perception. The combination of these fac-
torsmake elderly patients prone to rapid tissue injury and less
likely than younger patients to respond to mechanical sen-
sations as cues to change position. The elderly are more likely
to develop PUs because of insensitivity, weakness and hypo-
immunity. They are particularly likely to develop PUs of Stage
I and II, which are the most common stages observed in the
ICU [27]. The development of Stage I PU in an elderly patient is
regarded as a strong warning that the patient is at high risk of
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elderly patients with Stage I PUs deteriorate rapidly in the ICU
[28].
Nutrition has been identified as a potential risk factor for
PU risk. First, patients who are malnourished have more bony
prominences and are therefore at greater risk for PUs. Addi-
tionally, poor nutritional status results in decreased protein,
rendering tissue more susceptible to the effects of pressure.
Disease severity is also a risk factor for PU development,
and this risk is factored into the Acute Physiology, Age,
Chronic Health Evaluation (APACHE) III score [29]. The
APACHE III model utilizes the worst values of 12 physiological
variables during the first 24 h following ICU admission and an
evaluation of the patient's chronic health and admission
diagnosis to calculate the APACHE III predicted mortality
score. The APACHE III model has been widely validated and is
used by many ICUs to classify the severity of illness and pre-
dict hospital mortality. Higher APACHE III scores represent a
higher risk of death [30,31]. Additionally, diagnoses of sepsis,
Acinetobacter baumannii (Ab) or Pseudomonas aeruginosa (Pa) are
considered important intrinsic risk factors in the ICU [32].
Hematological measures include measures of Protein, Al-
bumin, Lymphopenia and Hemoglobin (Hb), and unusual re-
sults, including anemia and low serum albumin levels, may
have bearing on PU risk [33]. In the cardiothoracic ICU, pa-
tients can also be highly unstable hemodynamically, and this
deserves additional attention.
Moisture related variables include urinary incontinence,
fecal incontinence, dual incontinence and urinary catheters.
Moisture contributes to maceration, and this may make the
damaged epidermal layers more vulnerable to further pres-
sure related degradation.
3.2.1.2. Risk assessment scales (RAS). Patient assessment
using RAS should occur immediately following admission.
Although imperfect, this tool provides a practical method of
assessing PU risk and suggesting the appropriate in-
terventions to reduce risk. Themain assessment tools used in
ICUs in the UK, Europe and North America are the Braden and
Waterlow scales [34,35].
The Braden scale is a validated instrument for estimating
PU risk in the ICU that examines six criteria: sensory percep-
tion, moisture exposure, activity levels, patient mobility,
nutrition, and friction and shear force exposure [36]. When
assessing a patient for the Braden scale, exposure of the skin
to friction and shear forces is measured using a three-point
scale, while the other five items are measured using a four-
point scale. The sum of these measurements is the total
score, and this score can range from 6 to 23. A higher Braden
score indicates a lower PU risk, and patients are classified
according to the Braden scale as follows: very high risk (score
<9), high risk (score ranging from 10 to 12), moderate risk
(score ranging from 13 to 14), low risk (score ranging from 15 to
18) and no risk (score ranging from 19 to 23) [37]. Depending
upon the hospital making the assessment, the sensitivity of
the scale (using a cut-off score of 16) ranges from 71% to 100%
[38,39].
The Waterlow scale score is assigned based upon an
assessment of each of the following 10 risk factors: body
weight, continence, skin condition, nutritional status/appetite, age, sex, mobility, recent surgery, tissue perfusion
and neurological status. Adult scores on the Waterlow scale
range from 2 to 90. Low scores (<10) indicate a low risk of PU. A
patient with a score between 10 and 15 is considered at risk, a
patient with a score between 15 and 19 is at high risk and a
patient with a score greater than 20 is at very high risk. In a
recent study of 698 ICU patients, the best balance between
sensitivity (64.4%) and specificity (48.8%) was achieved at a
cut-off of 30 [40].
3.2.2. Skin assessment
Skin inspection and assessment should occur once during
each shift in the ICU, or more frequently in patients at an
elevated risk of PU development. The Institute for Clinical
Systems Improvement suggests that a risk assessment and
skin assessment be performed upon admission, and that
existing wounds be documented and treatment goals be
established at this time [41]. If a patient is considered to be at
risk for PU development, or if a patient has an existing PU, the
appropriate referrals to nutrition services and wound care
specialists should be initiated. ICU staff should also perform a
complete skin assessment as part of the risk screening of
patients in the ICU. During the regular skin assessment per-
formed during each ICU shift, any changes in skin condition
should be recorded, and the frequency of assessment should
increase if any alteration in skin condition is noticed [1]. The
presence of a Stage I PU increases the odds of advancement to
a Stage II PU by two to three fold; therefore, patients with
Stage I PUs should be very closely monitored. PUs often occur
over bony prominences such as the heels, occiput, sacrum
and ischial tuberosities [42,43], and the sacrum and heels are
the most frequent locations of PU occurrence [44].
Trunk wounds have historically been labeled as PUs;
however, confusion exists between incontinence-associated
dermatitis (IAD) and superficial PUs [45]. Therefore, it is
essential that staff training incorporate lessons concerning
the differentiation of IAD from PUs.
Incontinence is a common and difficult problem tomanage
in the intensive care setting. In addition to odor, embarrass-
ment and discomfort, incontinence increases the risk of skin
contamination, and this fecal exposure increases the patient's
PU risk. Factors associated with fecal matter, including
moisture, enzymes, bacteria and pH disruption may promote
skin maceration and epidermal erosion. The duration of
enteral feeding, the severity of disease and low albumin levels
are themain risk factors for incontinence among ICU patients.
Proper incontinencemanagement is a highly important factor
for patient health in the ICU, and a number of recent studies
have been conducted in an attempt to reduce the frequency of
fecal skin contamination in the ICU. Topical skin barriers may
assist in providing a barrier between moisture and skin. Low
quality evidence suggests that a pH-balanced cleanser may
have benefits when compared with soap and water to reduce
the incidence of Stage I or II PUs in patients with urinary or
fecal incontinence; however, overly frequent cleansing of the
skin because of diarrhea may damage the protective skin
barrier. Fecal containment devices are an effective way to
prevent skin damage due to moisture and enzyme action on
perianal tissues [19]. Reynolds MG recently reported [46] that
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preventing fecal skin contamination, but more studies are
required to ensure that it is safe and effective for patient use.
3.2.3. Surface support
Frequent turning and shifting of patient weight can help
manage the duration for which any given region of skin is
exposed to pressure, and high quality evidence indicates that
intelligently designed surfaces can also be used to help
minimize the exposure of patient's skin to potentially
damaging levels of pressure [47]. The current standard of
practice includes the use of pillows and wedges for the sup-
port, bridging and suspension of bony prominences off bed
surfaces. However, constant low-pressure surfaces, such as
foams, air, water and elastomeric mattresses, have been re-
ported to outperform conventional hospital mattresses in
preventing ulcer formation in the ICU [48].
A systematical review [19] concluded that there was low
quality evidence supporting the use of an alternative foam
mattress to produce a relative risk reduction (RRR) of 69% for
PUs when compared with a standard hospital mattress.
Another study reported the low quality evidence of a statis-
tically non-significant difference in the incidence of grade 2
PUs between persons using an alternating pressure mattress
and those using an alternating pressure overlay. Another low
quality evidence study reported that the use of an air sus-
pension bed in the ICU for stays of at least three days pro-
duced a statistically significant RRR of 76% in the incidence of
PUs when compared with a standard ICU bed.
3.2.4. Nutrition
Low albumin levels are an indicator of malnutrition (normal
levels fall between 36 and 52 g/L), and prealbumin levels
(normal levels fall between 16 and 35 mg/dL) may be a
reflection of current nutritional status. Albumin and pre-
albumin levels should be routinely assessed (weekly or bi-
weekly) to reveal trends in the adequacy of nutritional ther-
apy. Decreasing or low serial albumin or prealbumin levels
should alert the intensive care nurse to inform the physician
or nutritionist of a potential need to alter the current nutri-
tional therapy. Nurses should identify the nutrition status of
patients upon admission and advocate for the earliest possible
nutrition supplementation when necessary. Ensuring
adequate nutrition is particularly difficult in patients receiving
vasopressors because the vasoconstrictive action of vaso-
pressors constricts the gastric mucosa, preventing absorption
of nutrients. Additionally, enteral nutrition often causes loose
stools, and if patients are unable to indicate the need for a
bedpan, they must rely on frequent nursing assessment of
continence status. A recent study reported that among ICU
patients who received an enteral nutritional formula enriched
with fish oil containing u-3 light-chain polyunsaturated fatty
acids (PUFAs) and micronutrients, the incidence of new PUs
was significantly reduced [49,50]. This evidence is consistent
with that reported in the study by Theilla M [51].
3.2.5. Repositioning
Repositioning of the patient to off-load areas of high pressure
is an important component of PU prevention. A very high
quality evidence-based analysis [19] recently recommendedturning the patient at least once every 2 h on standard foam
mattress and once every 4 h on pressure redistribution
mattress; however, this recommendation was not supported
as a standard of care and it was suggested that the patient be
turned every 2 h, alternating from a lateral to a supine position
[2]. It remains unclear which repositioning protocols are the
most effective for PU prevention. In two systematic reviews
[52,53], researchers reported that there was insufficient evi-
dence to recommend any specific turning regimens for
patients.
Continuous bedside pressure mapping (CBPM) has been
used to assist PU prevention strategies in ICU patients by
identifying the magnitude of pressure experienced by various
body pressure points and helping to improve the positioning
of the body to minimize pressure. The technology empowers
clinicians with real-time feedback on repositioning strategies
and helps to off-load the at-risk body surface areas after
turning [54,55].
When repositioning, the patient's body should be turned
laterally 30 and the head of the bed elevated no higher than
30 to prevent pressure on the coccyx. However, this position
may promote ventilator-associated pneumonia (VAP) in
intubated patients and patients receiving enteral feeding. To
prevent VAP in at risk patients, it is suggested that the head of
the bed be elevated higher than 30. Frequently, intubated
patients may be restrained or treated with sedatives to pre-
vent removal of the endotracheal tube. These precautions
prevent the patient from changing position; however, caution
should be exercised if the patient is also hemodynamically
unstable, as he or she may not tolerate lateral position
changes [56]. There is a clear need for high quality, adequately
powered trials to assess the effects of patient position and
optimal frequency of repositioning on PU incidence.3.3. Evaluation after intervention
To ensure compliance with the care bundle, the adherence of
doctors and nurses to the protocols described above should be
periodically audited. Furthermore, statistical comparisons of
PU incidence before and after implementation of the care
bundle are essential to assess care bundle efficacy. The most
important factor for successful implementation of the care
bundle is the participation of whole team, only if physicians
and nurses work together and faithfully perform their duties
as described by the protocols of the care bundle can PUs be
effectively prevented.3.4. Quality improvement program
A quality improvement program is an essential element of the
long-term success of a PU care bundle. An effective quality
improvement program must emphasize the value of using
quality approaches to implement practice improvement and
incorporate new evidence into practice. The widespread
adoption of a multifaceted approach of providing information
togetherwith actual outcome data has resulted in a significant
change in culture [57]. The nurses who implement the care
bundle have been granted the responsibility and empowered
to adapt the care bundle to ensure that the correct aspects of
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lence of PUs in ICUs.
Many recently published quality improvement articles
have indicated that unit-based quality assurance projects are
particularly helpful in identifying the prevalence of PUs,
assessing the effectiveness of preventive measures and pre-
venting PUs in patients [58,59]. Unit-based quality initiatives
that document the number of days that have passed between
occurrences of hospital-acquired PUs are one method of
communicating this success in PU prevention. A two-nurse
handoff report and assessment on admission and shift
change, including the conduction of a skin assessment, en-
forces individual accountability for consistently carrying out
interventions designed to prevent the development of PUs.
These activities have demonstrated success in identifying
pressure areas before they develop into Stage I or greater PUs
[41].
3.5. Other PU management experiences and suggestions
Gunningberg [60] concluded that most patients with or at risk
for PUs did not receive an appropriate preventive care bundle
in the ICU. Their conclusion implies that variations in real
world practice might be a greater issue than originally sus-
pected, and they suggested the adoption of the standardized
nursing-terminology-based electronic nursing record (ENR)
system to document patient problems, nursing diagnoses,
nursing interventions/activities and nursing outcomes.
Two studies have suggested that every unit should identify
a staff memberwho focuses on the PU preventive care bundle.
This staff member is referred to as the “skin champion.” The
skin champion collaborates with the physician and consults
with awound ostomy and continence (WOC) nurse to improve
patient monitoring, management and treatment recommen-
dations [61].
An analysis of 28 studies [62] concluded that higher
staffing levels were associated with lower patient mortality in
ICUs. However, the nurse-to-patient and physician-to-bed
ratios do not make sense without including controls for the
throughput of the unit as well as the amount of care that
each patient needs. The ICU managers should improve the
staffing ratio, reform nursing shift arrangements and utilize
existing human resources effectively to improve care bundle
quality.4. Conclusions
The evidence-based care bundle includes five core measures:
Risk Assessment, Skin Assessment, Support Surfaces, Nutri-
tion and Repositioning. Each of these elements is essential in
clinical practice. For effective execution of the care bundle, a
team including nurses and doctors should be assembled and
given the appropriate education and training to execute the
care bundle in their ICU. For care bundle success, compliance
with all the requirements of the care bundle must be strictly
observed. A heightened awareness of each patients' PU risk
and unit pride contribute to highly effective implementation
of these preventive measures. However, even with effective
care bundle implementation, not all PUs can be preventedin long-term care settings. Interventions used in ICUs some-
times conflict with good skin care practices. Patient reposi-
tioning, for instance, can be difficult in combination with
certain ICU treatments. Therefore, there is a clear need for
high-quality, adequately powered trials to assess the effects of
position and the optimal frequency of repositioning to prevent
PU occurrence. Additional larger scale studies should also be
conducted to clarify the effectiveness of the preventive care
bundle approach to PU prevention.Conflicts of interest
The authors have no conflicts of interest to declare.r e f e r e n c e s
[1] National Pressure Ulcer Advisory Panel, European Pressure
Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance.
Prevention and treatment of pressure ulcers: clinical practice
guideline. In: Haesler Emily, editor. Osborne Park, Western
Australia: Cambridge Media; 2014.
[2] National Pressure Ulcer Advisory Panel. Pressure ulcers:
avoidable or unavoidable? Results of the National Pressure
Ulcer Advisory Panel Consensus Conference. OstomyWound
Manage 2011;57(2):24e37.
[3] Shahin ES, Dassen T, Halfens RJ. Pressure ulcer prevalence
and incidence in intensive care patients: a literature review.
Nurs Crit Care 2008;13(2):71e9.
[4] VanGilder C, Amlung S, Harrison P, Meyer S. Results of the
2008e2009 International Pressure Ulcer Prevalence Survey
and a 3-year, acute care, unit-specific analysis. Ostomy
Wound Manage 2009;55(11):39e45.
[5] Graves N, Birrell F, Whitby M. Effect of pressure ulcers on
length of hospital stay. Infect Control Hosp Epidemiol
2005;26(3):293e7.
[6] Krupp AE, Monfre J. Pressure ulcers in the ICU patient: an
update on prevention and treatment. Curr Infect Dis Rep
2015;17(3):468.
[7] Fu Wei, Lu Lianfang, Wei Lili, Li Guizhi, Wang Shuyun,
Wang Huifang. Investigation of prevalence rate and
management in hospital pressure ulcer. Nurs J Chin PLA
2015;32(8):16e20 [in Chinese].
[8] Berlowitz D, Lukas CA, Parker V, Silver J, Logan C. Preventing
pressure ulcers in hospitals: a toolkit for improving quality of
care. Rockville (MD): Agency for Healthcare Research and
Quality; 2011.
[9] Bennett G, Dealey C, Posnett J. The cost of pressure ulcers in
the UK. Age Ageing 2004;33(3):230e5.
[10] Hodgkinson B, Nay R, Wilson J. A systematic review of
topical skin care in aged care facilities. J Clin Nurs
2007;16(1):129e36.
[11] Demarre L, Van Lancker A, Van Hecke A, Verhaeghe S,
Grypdonck M, Lemey J, et al. The cost of prevention and
treatment of pressure ulcers: a systematic review. Int J Nurs
Stud 2015;52(11):1754e74.
[12] Robb E, Jarman B, Suntharalingam G, Higgens C, Tennant R,
Elcock K. Using care bundles to reduce in hospital mortality:
quantitative survey. BMJ 2010;340(15):861e3.
[13] Michel JM, Willebois S, Ribinik P, Barrois B, Colin D,
Passadori Y. As of 2012, what are the key predictive risk
factors for pressure ulcers? Developing French guidelines
for clinical practice. Ann Phys Rehabil Med 2012;55(7):
454e65.
i n t e r n a t i o n a l j o u rn a l o f n u r s i n g s c i e n c e s 2 ( 2 0 1 5 ) 3 4 0e3 4 7346[14] International guidelines. Pressure ulcer prevention:
prevalence and incidence in context. A consensus document.
London, England: MEP Ltd; 2009.
[15] Registered Nurses' Association of Ontario. Risk assessment
and prevention of pressure ulcers [Internet]. Toronto, ON:
The Association; 2009.
[16] Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S,
et al. Grading quality of evidence and strength of
recommendations. BMJ 2004;328(7454):1490.
[17] Gopalakrishna G, Mustafa RA, Davenport C, Scholten RJ,
Hyde C, Brozek J. Applying Grading of Recommendations
Assessment, Development and Evaluation (GRADE) to
diagnostic tests was challenging but doable. J Clin Epidemiol
2014;67(7):760e8.
[18] Eberlein-Gonska M, Petzold T, Helaß G, Albrecht DM,
Schmitt J. The incidence and determinants of decubitus
ulcers in hospital care: an analysis of routine quality
management data at a university hospital. Dtsch Arztebl Int
2013;110(33e34):550e6.
[19] Coleman S, Gorecki C, Nelson EA, Closs SJ, Defloor T,
Halfens R, et al. Patient risk factors for pressure ulcer
development: systematic review. Int J Nurs Stud
2013;50(7):974e1003.
[20] Manzano F, Navarro MJ, Roldan D, Moral MA, Leyva I,
Guerrero C, et al. Pressure ulcer incidence and risk factors in
ventilated intensive care patients. J Crit Care
2010;25(3):469e76.
[21] Moore Z, Cowman S. Pressure ulcer prevalence and
prevention practices in care of the older person in the
Republic of Ireland. J Clin Nurs 2012;21(3e4):362e71.
[22] Salgado DR, Favory R, Goulart M, Brimioulle S, Vincent JL.
Toward less sedation in the intensive care unit: a prospective
observational study. J Crit Care 2011;26(2):113e21.
[23] U¨lker Efteli E, Yapucu Gu¨nes U¨. A prospective, descriptive
study of risk factors related to pressure ulcer development
among patients in intensive care units. Ostomy Wound
Manage 2013;59(7):22e7.
[24] Nijs N, Toppets A, Defloor T, Bernaerts K, Milisen K, Van Den
Berghe G. Incidence and risk factors for pressure ulcers in the
intensive care unit. J Clin Nurs 2009;18(9):1258e66.
[25] Pokorny ME, Koldjeski D, Swanson M. Skin care intervention
for patients having cardiac surgery. Am J Crit Care
2003;12(6):535e44.
[26] Curry K, Kutash M, Chambers T, Evans A, Holt M, Purcell S. A
prospective, descriptive study of characteristics associated
with skin failure in critically ill adults. Ostomy Wound
Manage 2012;58(5):36e8. 40e3.
[27] Schuurman JP, Schoohoven L, Keller BP, van Ramshorst B. Do
pressure ulcers influence length of hospital stay in surgical
cardiothoracic patients? A prospective evaluation. J Clin
Nurs 2009;18(17):2456e63.
[28] Tayyib N, Coyer F, Lewis P. Saudi Arabian adult intensive
care unit pressure ulcer incidence and risk factors: a
prospective cohort study. Int Wound J 2015. http://dx.doi.org/
10.1111/iwj.12406.
[29] Knaus WA, Wagner DP, Draper EA, Zimmerman JE,
Bergner M, Bastos PG, et al. The APACHE III prognostic
system. Risk prediction of hospital mortality for critically ill
hospitalized adults. Chest 1991;100(6):1619e36.
[30] Ozyurek P, Yavuz M. Prevention of pressure ulcers in the
intensive care unit: a randomized trial of 2 viscoelastic foam
support surfaces. Clin Nurse Spec 2015;29(4):210e7.
[31] Bours GJJW, De Laat E, Halfens RJ, Lubbers M. Prevalence, risk
factor and prevention of pressure ulcers in Dutch intensive
care units. Results of a cross-sectional survey. Intensive Care
Med 2001;27(10):1599e605.
[32] Cooper KL. Evidence-based prevention of pressure ulcers in
the intensive care unit. Crit Care Nurse 2013;33(6):57e66.[33] Theaker C, Mannan M, Ives N, Soni N. Risk factors for
pressure sores in the critically ill. Anaesthesia
2000;55(3):221e4.
[34] Braden BJ, Bergstrom N. Predictive validity of the Braden
scale for pressure sore risk in a nursing home population.
Res Nurs Health 1994;17(6):459e70.
[35] Waterlow J. A policy that protects. The waterlow pressure
sore prevention/treatment policy. Prof Nurse 1991;6(5).
258,260,262e4.
[36] Serpa LF, Santos VL, Campanili TC, Queiroz M. Predictive
validity of the Braden scale for pressure ulcer risk in
critical care patients. Rev Lat Am Enfermagem
2011;19(1):50e7.
[37] Ayello EA, Braden B. How and why to do pressure ulcer risk
assessment. Adv Skin Wound Care 2002;15(3):125e33.
[38] Chan WS, Pang SM, Kwong EW. Assessing predictive validity
of the modified Braden scale for prediction of pressure ulcer
risk of orthopaedic patients in an acute care setting. J Clin
Nurs 2009;18(11):1565e73.
[39] Baris N, Karabacak BG, Alpar S‚ E. The use of the Braden scale
in assessing pressure ulcers in Turkey: a systematic review.
Adv Skin Wound Care 2015;28(8):349e57.
[40] Yurtsever S, Sayar S, Demirkan F, Tas‚delen B. Response to
Kottner, Commentary on Sayar S, Turgut S, Dogan H, Ekici
A, Yurtsever S, Demirkan F, Doruk N & Tas‚delen B (2009)
Incidence of pressure ulcers in intensive care unit patients
at risk according to theWaterlow Scale and factors
influencing the development of pressure ulcers. Journal of
Clinical Nursing 18, 765e774. J Clin Nurs
2010;19(23e24):3591e2.
[41] Perry D, Borchert K, Burke S, Chick K, Johnson K, Kraft W, et
al. Institute for Clinical Systems Improvement. Pressure
ulcer prevention and treatment protocol [Updated January
2012].
[42] Guan Xin, Wang Lei, Shao Xin. The incidence and risk factors
of pressure ulcer in the intensive care unit patients. Chin J
Nurs 2014;49(7):840e3 [in Chinese].
[43] Liu Fang. Using the care bundle to prevent pressure ulcer in
ICU. J Clin Med 2014;1(12):2240e1 [in Chinese].
[44] Huang Yuanling, Xiong Xiaoling, Ma Aiping, Deng Shaojun,
Tong Yajuan, Shao Yajuan. Application of intervention
bundle in the prevention of pressure ulcers in ICU patients.
Mod Clin Nurs 2013;12(4):28 [in Chinese].
[45] Beeckman D, Woodward S, Rajpaul K, Vanderwee K. Clinical
challenges of preventing incontinence-associated
dermatitis. Br J Nurs 2011;20(13):784e6. 788, 790.
[46] Reynolds MG, van Haren F. A case of pressure ulceration and
associated haemorrhage in a patient using a faecal
management system. Aust Crit Care 2012;25(3):188e94.
[47] Sprigle S, Sonenblum S. Assessing evidence supporting
redistribution of pressure for pressure ulcer prevention: a
review. J Rehabil Res Dev 2011;48(3):203e13.
[48] McInnes E, Jammali-Blasi A, Bell-Syer SE, Dumville JC,
Cullum N. Support surfaces for pressure ulcer prevention.
Cochrane Database Syst Rev 2011;13(4). CD001735.
[49] Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E,
Cohen J. Benefit of an enteral diet enriched with
eicosapentaenoic acid and gamma-linolenic acid in
ventilated patients with acute lung injury. Crit Care Med
2006;34(4):1033e8.
[50] Theilla M, Singer P, Cohen J, Dekeyser F. A diet enriched in
eicosapentanoic acid, gamma-linolenic acid and
antioxidants in the prevention of new pressure ulcer
formation in critically ill patients with acute lung injury: a
randomized, prospective, controlled study. Clin Nutr
2007;26(6):752e7.
[51] Theilla M, Schwartz B, Cohen J, Shapiro H, Anbar R, Singer P.
Impact of a nutritional formula enriched in fish oil and
i n t e r n a t i o n a l j o u r n a l o f nu r s i n g s c i e n c e s 2 ( 2 0 1 5 ) 3 4 0e3 4 7 347micronutrients on pressure ulcers in critical care patients.
Am J Crit Care 2012;21(4):e102e9.
[52] Reddy M, Gill SS, Rochon PA. Preventing pressure ulcers:a
systematic review. JAMA 2006;296(8):974e84.
[53] Moore ZE, Cowman S. Repositioning for treating pressure
ulcers. Cochrane Database Syst Rev 2015;1. CD006898.
[54] Sakai K, Sanada H, Matsui N, Nakagami G, Sugama J,
Komiyama C, et al. Continuous monitoring of interface
pressure distribution in intensive care patients for pressure
ulcer prevention. J Adv Nurs 2009;65(4):809e17.
[55] Cremasco MF, Wenzel F, Zanei SS, Whitaker IY. Pressure
ulcers in the intensive care unit: the relationship between
nursing workload, illness severity and pressure ulcer risk. J
Clin Nurs 2013;22(15e16):2183e91.
[56] Burk RS, Grap MJ. Backrest position in prevention of pressure
ulcers and ventilator-associated pneumonia: conflicting
recommendations. Heart Lung 2012;41(6):536e45.
[57] Li Jieqiong, Guo Cheng, Wang Xueliang, Zhao Xiaoli,
Liu Meili. Cluster nursing strategies in patients with
pressure ulcer in ICU. Chin J Pract Nurs 2012;28(15):36e7
[in Chinese].[58] Ballard N, McCombs A, Deboor S, Strachan J, Johnson M,
Smith MJ, et al. How our ICU decreased the rate of
hospital acquired pressure ulcers. J Nurs Care Qual
2008;23(1):92e6.
[59] Crumbley DR, Kane MA. Development of an evidence-
based pressure ulcer program at the National Naval
Medical Center: nurses' role in risk factor assessment,
prevention and intervention among young service
members returning from OIF/OEF. Nurs Clin North Am
2010;45(2):153e68.
[60] Gunningberg L. Are patients with or at risk of pressure ulcers
allocated appropriate prevention measures? Int J Nurs Pract
2005;11(2):58e67.
[61] Anderson M, Finch Guthrie P, Kraft W, Reicks P, Skay C,
Beal AL, et al. Universal pressure ulcer prevention bundle
with WOC nurse support. J Wound Ostomy Continence Nurs
2015;42(3):217e25.
[62] Kane RL, Shamliyan TA, Mueller C, Duval S, Wilt TJ. The
association of registered nurse staffing levels and patient
outcomes: systematic review and meta-analysis. Med Care
2007;45(12):1195e204.
